cro.directory
← Home
CatSci logo

CatSci

Your trusted partner for small molecule and complex synthetic medicines development

UK-based partner for small molecule and complex synthetic medicines, offering route selection, process development, GMP drug substance manufacture and analytical services across four European and UK sites.

Phases

Services

Modalities

About this organization

CatSci is a UK-based strategic outsourcing partner for global biotech and pharma teams developing small molecule therapies and complex synthetic medicines.

Scientific platforms

  • Route selection and catalysis-enabling chemistry
  • Process development and GMP drug substance manufacturing
  • Analytical services and purification and separation science
  • High-throughput experimentation and nitrosamine risk assessment

Modalities

  • Small molecules
  • Oligonucleotides
  • Peptides
  • TACs and glues
  • Complex synthetic medicines

Development stages

The site lists support from preclinical design, make, test and select work and IND/IMPD-enabling activity through Phase I and Phase II clinical development, Phase III process development and control, and post-approval support.

Facilities and team

  • Four European and UK sites with 14 laboratories
  • £5m invested in facilities over the last five years
  • Around 80% of the team is PhD educated
  • More than 15 years of drug development experience

Sustainability

The company cites My Green Lab and EcoVadis certifications and reports a Gold EcoVadis sustainability rating.

Client base

The site states that seven of the top 10 pharma companies work with CatSci and that 55% of new projects are collaborations with biotechs. It also states a lead time of under one month to start a new project.

Similar profiles by shared services, phases, and indications.

View all alternatives →See similar CROs ranked by shared capabilities

Submit a verified review for this organization.

Markdown mirror: /companies/catsci.md